Company news
BeOne Medicines Ltd. news in 2023
BeOne Medicines Ltd.'s news releases, calls and decks from 2023, newest first.
Announcement on Initial Public Offering of Restricted Shares under Strategic Allotment for Circulation
December 7, 2023
Announcement on Adjusting Investment Amount of Raised Funds Invested in Investment Subproject Financed by Raised Funds
November 13, 2023
Announcement on Convening 2023 3rd Quarter Performance Meeting
November 6, 2023
Announcement on Voluntary Disclosure of National Institute for Health and Care Excellence's Recommendation of Baiyueze (Zanubrutinib Capsules) for Treatment of Adult Patients with Chronic Lymphocytic Leukemia
October 20, 2023
Announcement on Voluntary Disclosure of Progress in Obtaining Positive Registration of Baize'an (Tislelizumab Injection) in Europe and America
September 19, 2023